Abstract:Abstract OBJECTIVES In this study, we aimed to compare infants with univentricular hearts who underwent an initial ductus stenting to those receiving a surgical systemic to pulmonary shunt. METHODS All infants with univentricular heart and ductal-dependent pulmonary blood flow who underwent initial palliation with either a ductus stenting or a surgical systemic to pulmonary shunt between 2009 and 2022 were reviewed. Outcomes were compared after ductus stenting or systemic to pulmonary shunt including survival, probability of re-interventions and the probability to reach stage II palliations. RESULTS A total of 130 patients were evaluated, including 49 ductus stenting and 81 systemic to pulmonary shunts. The most frequent primary diagnosis was tricuspid atresia in 27, followed by pulmonary atresia with intact ventricular septum in 19 patients. There was comparable hospital mortality (2.0% stent vs 3.7% surgery, p = 0.91) between the groups, but shorter intensive care unit stay (median 1 vs 7 days, p < 0.01) and shorter hospital stay (median 7 vs 17 days, p < 0.01) were observed in patients with initial ductus stenting, compared to those with systemic to pulmonary shunt. However, acute procedure-related complications were more frequently observed in patients with ductus stenting, compared with those with systemic to pulmonary shunt (20.4 vs 6.2%, p = 0.01), and 10 patients needed a shunt procedure after the initial ductus stent. The cumulative incidence of reaching stage II was similar between ductus stenting and systemic to pulmonary shunt (88.0 vs 90.6% at 12 months, p = 0.735). Pulmonary artery index (median 194 vs 219 mm2/m2, p = 0.93) at stage II was similar between patients with ductus stenting and systemic to pulmonary shunt. However, the ratio of the left to the right pulmonary artery index (0.69 (0.45–0.95) vs 0.86 (0.51–0.84), p = 0.015) was higher in patients who reached stage II with surgical shunt physiology, compared with patients with ductus stent physiology. CONCLUSIONS After initial ductus stenting in infants with univentricular heart, survival is comparable and post-procedural recovery shorter, but more acute stent dysfunctions and lower development of left pulmonary artery are observed, compared to acute shunt dysfunctions. The less invasive procedure and shorter hospital stay is at the expense of more stent reinterventions.

Interstage Home Monitoring for Infants With Single Ventricle Heart Disease: Education and Management: A Scientific Statement From the American Heart Association

A systematic review on the role of home monitoring in interstage management of infants with Hypoplastic Left Heart Syndrome or single ventricle defect

Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association

Risk Factors for Death or Transplant After Stage 2 Palliation for Single Ventricle Heart Disease

Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association

Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association

Stage 1 and 2 Palliation: Comparing Ductal Stenting and Aorto-Pulmonary Shunts in Single Ventricles with Duct-Dependent Pulmonary Blood Flow

Automated Prediction of Cardiorespiratory Deterioration in Patients With Single Ventricle

Childhood Opportunity and Acute Interstage Outcomes: A National Pediatric Cardiology Quality Improvement Collaborative Analysis

Machine Learning to Predict Interstage Mortality Following Single Ventricle Palliation: A NPC-QIC Database Analysis

Single Ventricular Assist Device Care and Outcomes for Failed Stage I Palliation: A Single-Center Decade of Experience

Periprocedural Management and Multidisciplinary Care Pathways for Patients With Cardiac Implantable Electronic Devices: A Scientific Statement From the American Heart Association

Hybrid stage 1 palliation with simultaneous off-pump ventricular assist device placement in neonates with high-risk single ventricle anatomy: Initial experience

Initial Experience with Telemedicine for Interstage Monitoring in Infants with Palliated Congenital Heart Disease

Comparison of pulmonary artery growth between ductus stent and systemic-to-pulmonary shunt as single-ventricle palliation

Comparison of ductus stent versus surgical systemic to pulmonary shunt as initial palliation in patients with univentricular heart

Days alive and out of hospital for children born with single-ventricle heart disease

Trisomy 21 and Congenital Heart Disease: Impact on Health and Functional Outcomes From Birth Through Adolescence: A Scientific Statement From the American Heart Association

Are Parent Discharge Readiness Scores Effective for the Congenital Heart Disease Patients After Cardiac Surgery?

Cardiovascular Drug Therapy during Interstage After Hybrid Approach: A Single-Center Experience in 51 Newborns with Hypoplastic Left Heart

SSSH: Responsive soothing bassinet feasibility study for infants with congenital heart disease after cardiac surgery